MDR1 gene therapy (Crucell)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMDR1 gene therapy (Crucell)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionP-glycoprotein 1 inhibitors
TargetsP-glycoprotein 1
Therapy Area/IndicationsUrinary Bladder NeoplasmsBreast NeoplasmsLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCrucell Holland Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrucell Holland Bv
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsBreast NeoplasmsLymphoma, Non-Hodgkin

Other Information

ATC CodeN/A
Related LinksN/A